Fidelity Advisor Biotechnology Fund - Class C (FBTCX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
20.74
+0.10 (0.48%)
Jul 3, 2025, 4:00 PM EDT
-10.26%
Fund Assets 1.28B
Expense Ratio 1.76%
Min. Investment $0.00
Turnover 73.00%
Dividend (ttm) 1.44
Dividend Yield 6.95%
Dividend Growth n/a
Payout Frequency n/a
Ex-Dividend Date Dec 26, 2024
Previous Close 20.64
YTD Return -1.57%
1-Year Return -10.26%
5-Year Return 3.74%
52-Week Low 17.04
52-Week High 27.16
Beta (5Y) n/a
Holdings 85
Inception Date Dec 27, 2000

About FBTCX

Fidelity Advisor Biotechnology Fund Class C is a mutual fund that primarily invests in companies within the biotechnology sector. Its central objective is capital appreciation, achieved by allocating at least 80% of its assets to securities of firms engaged in the research, development, manufacture, and distribution of biotechnological products, services, and processes. The fund is notably concentrated in the healthcare industry, focusing on businesses that benefit significantly from advances in biotechnology, such as pharmaceuticals and innovative therapeutic providers. The portfolio often holds a high percentage of assets in its top holdings, which typically include leading biotechnology and pharmaceutical companies. With total assets exceeding $1.3 billion, the fund plays a prominent role in offering investors exposure to the dynamic and innovation-driven field of biotechnology. The fund’s investment style is characterized as “mid-blend,” and it is managed with an emphasis on capturing the growth potential within the sector while balancing risk through diversified holdings of both large and emerging biotech firms. This fund is part of Fidelity’s suite of sector-specific offerings, serving investors seeking targeted access to the biotechnology market.

Fund Family Fidelity
Category Health
Stock Exchange NASDAQ
Ticker Symbol FBTCX
Share Class Class C
Index S&P 500 TR

Performance

FBTCX had a total return of -10.26% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.74%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol Share Class Expense Ratio
FIJYX Class Z 0.61%
FBTIX Class I 0.74%
FBTAX Class A 1.01%
FBTTX Class M 1.29%

Top 10 Holdings

60.00% of assets
Name Symbol Weight
AbbVie Inc. ABBV 19.38%
Gilead Sciences, Inc. GILD 8.75%
Alnylam Pharmaceuticals, Inc. ALNY 7.26%
Ascendis Pharma A/S ASND 5.53%
Amgen Inc. AMGN 5.25%
argenx SE ARGX 4.92%
Neurocrine Biosciences, Inc. NBIX 2.63%
Nuvalent, Inc. NUVL 2.38%
Vaxcyte, Inc. PCVX 1.99%
Viridian Therapeutics, Inc. VRDN 1.90%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Dec 26, 2024 $1.441 Dec 27, 2024
Dec 17, 2021 $5.241 Dec 20, 2021
Jul 9, 2021 $0.006 Jul 12, 2021
Dec 18, 2020 $2.732 Dec 21, 2020
Dec 20, 2019 $1.849 Dec 23, 2019
Dec 7, 2018 $0.589 Dec 10, 2018
Full Dividend History